Ashvattha Therapeutics: Funding, Investors & Team (Oct 2026)
Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.
Ashvattha Therapeutics has raised $119M across 2 funding rounds on record, the most recent a Series B of $50.0M announced in Jan 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ashvattha Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Ashvattha Therapeutics Funding Rounds
Ashvattha Therapeutics raised $69.0M in a Series B announced in Apr 2022.
2.8 years later, a Series B of $50.0M was announced in Jan 2025.
Ashvattha Therapeutics Founders and Leadership Team
Contact details for the Ashvattha Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Ashvattha Therapeutics Funding Compared to Other Biotechnology Startups
Ashvattha Therapeutics' latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ashvattha Therapeutics in Biotechnology and Redwood City
Companies Similar to Ashvattha Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Ashvattha Therapeutics Funding FAQs
What does Ashvattha Therapeutics do?
Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.
How much funding has Ashvattha Therapeutics raised?
Ashvattha Therapeutics has raised $119M across 2 rounds on record. The most recent is a Series B of $50.0M announced in Jan 2025.
When did Ashvattha Therapeutics last raise funding?
Ashvattha Therapeutics' most recent funding round on record is a Series B of $50.0M, announced in Jan 2025.
Who founded Ashvattha Therapeutics?
FundedIQ lists Jeffrey Cleland (Founder) at Ashvattha Therapeutics.
Where is Ashvattha Therapeutics headquartered?
Ashvattha Therapeutics is based in Redwood City, California, United States.
How many employees does Ashvattha Therapeutics have?
Ashvattha Therapeutics is in the 11-50 employee band.
How does Ashvattha Therapeutics' funding compare to other Biotechnology startups?
Ashvattha Therapeutics' latest round of $50.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Ashvattha Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ashvattha Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.